Financial statements All4Pharmacy
Balance sheet data of ALL4PHARMACY
|
Year
|
2020
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 1 134 041,31 | 3 708 883,97 | 4 600 238,06 |
| A. Fixed assets | 0,00 | 1 118 936,95 | 1 576 020,76 |
| B. Current assets | 1 134 041,31 | 2 589 947,02 | 3 024 217,30 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | - |
| Total liabilities | 1 134 041,31 | 3 708 883,97 | 4 600 238,06 |
| A. Equity | -6 130,95 | -425 423,80 | 307 273,14 |
| B. Liabilities and provisions for liabilities | 1 140 172,26 | 4 134 307,77 | 4 292 964,92 |
| I. Long-term liabilities | 445 023,95 | 2 230 000,00 | 2 300 000,00 |
| II. Short-term liabilities | 695 148,31 | 1 904 307,77 | 1 967 160,44 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.